Net Cash Provided by (Used in) Operating Activities |
-941K |
USD |
+28.6% |
Dec 31, 2023 |
Q4 2023 |
Net Cash Provided by (Used in) Financing Activities |
-114M |
USD |
-197% |
Dec 31, 2023 |
Q4 2023 |
Net Cash Provided by (Used in) Investing Activities |
114M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares, Issued |
3.25M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-423K |
USD |
-153% |
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
8.65K |
USD |
-98.9% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Valuation Allowance |
549K |
USD |
+58% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
549K |
USD |
+58% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-202K |
USD |
+41.6% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
1.61M |
USD |
+6397% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
72.8K |
USD |
-71% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |